Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
August 12 2024 - 8:05AM
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of
life science reagents and services to researchers and biotech
innovators, is scheduled to participate in the following investor
conferences in August and September.
On August 14, 2024, at 11:00 a.m. PDT/ 2:00 p.m. EDT, Trey
Martin, Chief Executive Officer, will participate in a panel
discussion of the Critical Components of the Genomic Medicine
Supply Chain at the UBS Genomic Medicine Conference in Dana Point,
CA.
On September 4, 2024, at 6:30 a.m. PDT/ 9:30 a.m. EDT, Trey
Martin, Chief Executive Officer, and Kevin Herde, Chief Financial
Officer, will participate in a fireside chat at the Wells Fargo
Healthcare Conference in Boston, MA.
On September 5, 2024, at 1:50 p.m. PDT/ 4:50 p.m. EDT, Trey
Martin, Chief Executive Officer, and Kevin Herde, Chief Financial
Officer, will participate in a fireside chat at the Morgan Stanley
Healthcare Conference in New York, NY.
A live webcast of each presentation will be available to all
interested parties on the Maravai LifeSciences Investor Relations
website, under News & Events, Upcoming events. An archived
version of the webcast will also be available on the Maravai
website after the event is completed.
About Maravai
Maravai is a leading life sciences company providing critical
products to enable the development of drug therapies, diagnostics,
and novel vaccines and to support research on human diseases.
Maravai’s companies are leaders in providing products and services
in the fields of nucleic acid synthesis and biologics safety
testing to many of the world’s leading biopharmaceutical, vaccine,
diagnostics, and cell and gene therapies companies.
For more information about Maravai LifeSciences, visit
www.maravai.com.
Contact Information:
Investor Contact: Deb Hart Maravai LifeSciences +1 858-988-5917
ir@maravai.com
Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart
From Oct 2024 to Nov 2024
Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart
From Nov 2023 to Nov 2024